FDA Says Philips CPAP Recall Notice Is Inadequate, Orders Company To Do More
SILVER SPRING, Md. — Saying Philips Respironics’ consumer notification about its recall of continuous positive air pressure (CPAP) devices is inadequate, the Food and Drug Administration on March 10 took the...To view the full article, register now.
Already a subscriber? Click here to view full article